Inventor · disambiguated record
Jorge Garcia Fortanet
Also filed as: FORTANET JORGE GARCIA
16 granted patents·7 pending applications·72 citations·filing 2015–2023
92Inventor score
Top patents by PatentIndex Score
23 records- 0192US10968235B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2019·Granted Apr 6, 2021·3 cites·3 claims
- 0292US10934285B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted Mar 2, 2021·5 cites·5 claims
- 0392US10077276B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Sep 18, 2018·15 cites·22 claims
- 0490US10336774B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2018·Granted Jul 2, 2019·7 cites·22 claims
- 0590US10093646B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2015·Granted Oct 9, 2018·7 cites·10 claims
- 0690US9815813B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2015·Granted Nov 14, 2017·13 cites·8 claims
- 0788US10301278B21-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2NOVARTIS AG·Filed 2017·Granted May 28, 2019·8 cites·7 claims
- 0886US10287266B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted May 14, 2019·8 cites·13 claims
- 0981US10975080B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·3 claims
- 1079US2024199609A1Compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2023·Application pending·0 cites
- 1178US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 1277US2022073537A1N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 1375US11952386B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Apr 9, 2024·0 cites·12 claims
- 1475US2022348553A11-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of shp2NOVARTIS AG·Filed 2022·Application pending·0 cites
- 1574US12209098B2N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2021·Granted Jan 28, 2025·0 cites·26 claims
- 1670US11905283B2Compounds and compositions for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Feb 20, 2024·0 cites·8 claims
- 1769US11401259B21-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2NOVARTIS AG·Filed 2020·Granted Aug 2, 2022·0 cites·4 claims
- 1866US10308660B2Compounds and compositions for inhibiting the activity of SHP2CHEN ZHUOLIANG·Filed 2016·Granted Jun 4, 2019·1 cites·20 claims
- 1966US2021309663A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2065US2022089597A1Compounds and compositions for inhbiting the activity of shp2NOVARTIS AG·Filed 2021·Application pending·0 cites
- 2164US10774065B21-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2CHEN CHRISTINE HIU TUNG·Filed 2018·Granted Sep 15, 2020·0 cites·3 claims
- 2253US2023416262A1Trpml modulatorsCASMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2350US2023104936A1Trpml modulatorsCASMA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jorge Garcia Fortanet files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →